gluesnail0
About
In vivo anti-V-ATPase antibody therapy setbacks ovarian cancer expansion by simply growing antitumor resistant responses.
In vivo anti-V-ATPase antibody therapy setbacks ovarian cancer expansion by simply growing antitumor resistant responses.